594-36-5

Applied Filters:

Keyword:'594-36-5'

Showing 1-3 of 3 results for "594-36-5" within Papers

Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats.

Roger D Reidelberger et al.

American journal of physiology. Regulatory, integrative and comparative physiology, 295(2), R449-R458 (2008-06-14)

Chronic administration of anorexigenic substances to experimental animals by injections or continuous infusion typically produces either no effect or a transient reduction in food intake and body weight. Our aim here was to identify an intermittent dosing strategy for intraperitoneal

Quantification of folate in fruits and vegetables: A fluorescence-based homogeneous assay.

Harry Martin et al.

Analytical biochemistry, 402(2), 137-145 (2010-04-07)

A high-throughput, homogeneous, fluorescence polarization, and fluorescence intensity assay has been developed for the measurement of folate in fruits and vegetables. This assay is based on the competitive displacement of the fluorescent folate ligands Alexa Fluor (Alexa) 594-folate and Alexa

Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine.

M J Bonifácio et al.

Epilepsia, 42(5), 600-608 (2001-05-31)

BIA 2-093 [(S)-(-)-10-acetoxy-10,11-dihydro-5H-dibenz/b,f/azepine-5-carboxamide] is endowed with an anticonvulsant potency similar to that of carbamazepine (CBZ), but produces less cognitive and motor impairment. This study evaluated whether voltage-gated sodium channels (VGSCs) are a primary locus for the action of BIA 2-093.

Page 1 of 1